Total Payments
$8,791
2024 Payments
$1,595
Companies
42
Transactions
474
Medicare Patients
865
Medicare Billing
$63,804
Payment Breakdown by Category
Food & Beverage$8,770 (99.8%)
Education$20.76 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,770 | 472 | 99.8% |
| Education | $20.76 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,136 | 72 | $0 (2024) |
| GlaxoSmithKline, LLC. | $922.63 | 48 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $831.06 | 41 | $0 (2024) |
| ABBVIE INC. | $815.36 | 51 | $0 (2024) |
| Amarin Pharma Inc. | $708.03 | 48 | $0 (2022) |
| Amgen Inc. | $536.44 | 30 | $0 (2024) |
| Dexcom, Inc. | $502.01 | 6 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $469.22 | 17 | $0 (2024) |
| Lilly USA, LLC | $355.65 | 24 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $340.18 | 21 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,595 | 74 | Novo Nordisk Inc ($278.44) |
| 2023 | $2,030 | 109 | ABBVIE INC. ($371.79) |
| 2022 | $2,110 | 110 | Amgen Inc. ($235.84) |
| 2021 | $3,056 | 181 | Amarin Pharma Inc. ($600.24) |
All Payment Transactions
474 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $24.10 | General |
| Category: Heart Failure and Hypertension | ||||||
| 12/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Diabetes | ||||||
| 12/17/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 12/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: DIABETES | ||||||
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $9.53 | General |
| 11/26/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $13.83 | General |
| Category: Heart Failure and Hypertension | ||||||
| 11/21/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $79.96 | General |
| Category: Endocrinology | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $24.55 | General |
| Category: VACCINES | ||||||
| 11/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $8.64 | General |
| 11/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: Inflammation | ||||||
| 10/17/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.27 | General |
| Category: DIABETES | ||||||
| 10/06/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.37 | General |
| 09/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Obesity | ||||||
| 09/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: RESPIRATORY | ||||||
| 09/24/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: Biological | ||||||
| 09/18/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $32.81 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: OUD | ||||||
| 08/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $25.27 | General |
| Category: DIABETES | ||||||
| 08/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $10.08 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 445 | 613 | $107,351 | $29,240 |
| 2022 | 7 | 246 | 306 | $68,884 | $20,039 |
| 2021 | 3 | 111 | 111 | $21,738 | $9,444 |
| 2020 | 2 | 63 | 63 | $11,641 | $5,081 |
Total Patients
865
Total Services
1,093
Medicare Billing
$63,804
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 110 | 177 | $56,640 | $13,798 | 24.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 47 | 47 | $15,322 | $4,872 | 31.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 41 | 47 | $10,716 | $2,428 | 22.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 29 | 29 | $4,756 | $2,086 | 43.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $6,345 | $1,350 | 21.3% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 19 | 19 | $4,047 | $1,232 | 30.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 94 | 127 | $2,111 | $1,042 | 49.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 30 | 30 | $2,220 | $907.20 | 40.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 15 | 77 | $2,772 | $704.25 | 25.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 12 | 12 | $888.00 | $332.64 | 37.5% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 16 | 16 | $752.00 | $243.84 | 32.4% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 17 | 17 | $782.00 | $243.84 | 31.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 84 | 117 | $37,379 | $9,534 | 25.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 52 | 52 | $14,410 | $5,802 | 40.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 45 | 59 | $13,452 | $3,308 | 24.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 11 | 11 | $1,804 | $753.94 | 41.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 11 | 11 | $697.00 | $315.26 | 45.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 15 | 27 | $916.00 | $240.40 | 26.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 28 | 29 | $226.00 | $85.38 | 37.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 80 | 80 | $21,120 | $9,106 | 43.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 18 | 18 | $540.00 | $298.50 | 55.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 13 | 13 | $78.00 | $39.00 | 50.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 49 | 49 | $11,221 | $4,851 | 43.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 14 | 14 | $420.00 | $230.66 | 54.9% |
About Dawn Diaz, ARNP
Dawn Diaz, ARNP is a Nurse Practitioner healthcare provider based in Yulee, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/24/2015. The National Provider Identifier (NPI) number assigned to this provider is 1366827925.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dawn Diaz, ARNP has received a total of $8,791 in payments from pharmaceutical and medical device companies, with $1,595 received in 2024. These payments were reported across 474 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($8,770).
As a Medicare-enrolled provider, Diaz has provided services to 865 Medicare beneficiaries, totaling 1,093 services with total Medicare billing of $63,804. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Yulee, FL
- Active Since 07/24/2015
- Last Updated 11/18/2024
- Taxonomy Code 363L00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1366827925
Products in Payments
- Vascepa (Drug) $708.03
- JARDIANCE (Drug) $603.83
- TRELEGY ELLIPTA (Drug) $565.74
- Dexcom G6 Transmitter (Medical Supply) $502.01
- Rybelsus (Drug) $360.48
- XARELTO (Drug) $340.18
- Ozempic (Drug) $338.12
- VRAYLAR (Drug) $332.33
- Otezla (Drug) $303.27
- UBRELVY (Drug) $245.18
- SHINGRIX (Biological) $223.44
- BREZTRI (Drug) $216.51
- Kerendia (Drug) $213.19
- Aimovig (Biological) $204.17
- NURTEC ODT (Drug) $174.08
- RYBELSUS (Drug) $163.48
- AIRSUPRA (Drug) $149.44
- QULIPTA (Drug) $147.83
- MYRBETRIQ (Drug) $137.81
- SYNJARDY (Drug) $135.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Yulee
Mrs. Sonia Burns, Aprn, APRN
Nurse Practitioner — Payments: $2,299
Nurse Practitioner $2,299
Michelle Pendleton, Aprn, APRN
Nurse Practitioner — Payments: $1,235
Nurse Practitioner $1,235
Kalli Ackerman, Aprn, APRN
Nurse Practitioner — Payments: $1,178
Nurse Practitioner $1,178
Ms. Jennifer Mertiff, Aprn Fnp-C, APRN FNP-C
Nurse Practitioner — Payments: $129.68
Nurse Practitioner $129.68
Claudette Chretien
Nurse Practitioner
Nurse Practitioner